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Accuracy of Chest Computed Tomography in Distinguishing Cystic
Pleuropulmonary Blastoma From Benign Congenital Lung Malformations
in Children
Abigail J. Engwall-Gill, MD; Sherwin S. Chan, MD, PhD; Kevin P. Boyd, DO; Jacqueline M. Saito, MD, MSCI; Mary E. Fallat, MD; Shawn D. St Peter, MD;
Stephanie Bolger-Theut, DO; Eric J. Crotty, MD; Jared R. Green, MD; Rebecca L. Hulett Bowling, MD; Sachin S. Kumbhar, MD; Mantosh S. Rattan, MD;
Cody M. Young, DO; Joseph K. Canner, MHS; Katherine J. Deans, MD, MHSc; Samir K. Gadepalli, MD, MBA; Michael A. Helmrath, MD; Ronald B. Hirschl, MD;
Rashmi Kabre, MD; Dave R. Lal, MD, MPH; Matthew P. Landman, MD, MPH; Charles M. Leys, MD; Grace Z. Mak, MD; Peter C. Minneci, MD, MHSc;
Tiffany N. Wright, MD; Shaun M. Kunisaki, MD, MSc; for the Midwest Pediatric Surgery Consortium

Abstract
IMPORTANCE The ability of computed tomography (CT) to distinguish between benign congenital
lung malformations and malignant cystic pleuropulmonary blastomas (PPBs) is unclear.
OBJECTIVE To assess whether chest CT can detect malignant tumors among postnatally detected
lung lesions in children.

Key Points
Question Can chest computed
tomography be used to detect
malignant tumors in children with cystic
lung lesions?
Findings In this multi-institutional casecontrol study of 40 children with cystic

DESIGN, SETTING, AND PARTICIPANTS This retrospective multicenter case-control study used a

lung lesions, the sensitivity for detecting

consortium database of 521 pathologically confirmed primary lung lesions from January 1, 2009,

pleuropulmonary blastoma was 58%,

through December 31, 2015, to assess diagnostic accuracy. Preoperative CT scans of children with

and the specificity was 83%. Although

cystic PPB (cases) were selected and age-matched with CT scans from patients with postnatally

high suspicion for malignancy was

detected congenital lung malformations (controls). Statistical analysis was performed from January

significantly correlated with malignant

18 to September 6, 2020. Preoperative CT scans were interpreted independently by 9 experienced

tumors, the diagnostic accuracy was

pediatric radiologists in a blinded fashion and analyzed from January 24, 2019, to September

81%, and agreement among radiologists

6, 2020.

was poor.
Meaning This study suggests that

MAIN OUTCOMES AND MEASURES Accuracy, sensitivity, and specificity of CT in correctly
identifying children with malignant tumors.

computed tomography may not
accurately and reliably identify
pleuropulmonary blastoma; operative

RESULTS Among 477 CT scans identified (282 boys [59%]; median age at CT, 3.6 months [IQR,
1.2-7.2 months]; median age at resection, 6.9 months [IQR, 4.2-12.8 months]), 40 cases were
extensively reviewed; 9 cases (23%) had pathologically confirmed cystic PPB. The median age at CT
was 7.3 months (IQR, 2.9-22.4 months), and median age at resection was 8.7 months (IQR, 5.0-24.4

management is therefore
recommended to confirm pathologic
diagnosis in postnatally detected
cystic lesions.

months). The sensitivity of CT for detecting PPB was 58%, and the specificity was 83%. High
suspicion for malignancy correlated with PPB pathology (odds ratio, 13.5; 95% CI, 2.7-67.3; P = .002).
There was poor interrater reliability (κ = 0.36 [range, 0.06-0.64]; P < .001) and no significant
difference in specific imaging characteristics between PPB and benign cystic lesions. The overall
accuracy rate for distinguishing benign vs malignant lesions was 81%.

+ Invited Commentary
+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

CONCLUSIONS AND RELEVANCE This study suggests that chest CT, the current criterion standard
imaging modality to assess the lung parenchyma, may not accurately and reliably distinguish PPB
from benign congenital lung malformations in children. In any cystic lung lesion without a prenatal
diagnosis, operative management to confirm pathologic diagnosis is warranted.
JAMA Network Open. 2022;5(6):e2219814. doi:10.1001/jamanetworkopen.2022.19814
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Introduction
Congenital lung malformations (CLMs) are a group of benign pulmonary anomalies that include
bronchogenic cysts, bronchopulmonary sequestration (BPS), congenital lobar emphysema, and
congenital pulmonary airway malformations (CPAMs).1-3 The incidence of these lung lesions has
increased during the past 20 years owing to the more widespread use of imaging, and some studies
suggest that these lung lesions occur in up to 1 in 2000 children.4,5 Congenital lung malformations
are known to be associated with a wide spectrum of disease, ranging from in utero hydrops and
respiratory distress at birth to pneumothorax and recurrent pneumonia during the first several years
of life.6,7 Although symptomatic lesions are ubiquitiously managed by surgical resection,8-11
asymptomatic lesions during early infancy have an unclear natural history. Accordingly, some
clinicians have espoused nonoperative management strategies for asymptomatic CLMs and
recommend delayed surgical resection only if clinical symptoms arise.12-14
Although malignant transformation of benign CLMs is thought to be uncommon,15 a recent
multicenter study16 confirmed that approximately 10% of cystic lung lesions that were initially
diagnosed in the postnatal period may harbor cystic (type I) pleuropulmonary blastoma (PPB), a
malignant and potentially lethal lung tumor associated with the DICER1 (OMIM 601200) variant.17
Many PPBs have a similar appearance to macrocystic CPAMs on computed tomography (CT) scans,
the current criterion standard imaging modality to assess the lung parenchyma in children, based on
several retrospective reviews.15,18-23 The reliability of CT in cases of PPB remains unknown.24
Given ongoing concerns about misdiagnosing PPB as a benign macrocytic CPAM, we used a
multi-institutional consortium registry to formally evaluate the CT characteristics of cystic PPB and
benign CLMs. The primary aim of this study was to assess whether a cohort of board-certified
pediatric radiologists could accurately discern PPB from CLMs when evaluating the same CT images.
We hypothesized that experienced radiologists with an increased awareness of PPB could reliably
diagnose most PPBs and CPAMs with acceptable agreement.

Methods
Study Design, Setting, Participants
A central reliance agreement was approved by the institutional review boards of all institutions
associated with the Midwest Pediatric Surgery Consortium, a group of 11 US tertiary care children’s
hospitals located in 7 contiguous states serving an estimated total population of 58 million people
(Children’s Mercy Hospital, Kansas City, Missouri; Children’s Wisconsin, Milwaukee; St Louis
Children’s Hospital, St Louis, Missouri; Norton Children’s Hospital, Louisville, Kentucky; Cincinnati
Children’s Hospital, Cincinnati, Ohio; Ann & Robert H. Lurie Children’s Hospital, Chicago, Illinois;
Nationwide Children’s Hospital, Columbus, Ohio; C. S. Mott & Von Voigtlander Children’s Hospital,
Ann Arbor, Michigan; Riley Children’s Hospital, Indianapolis, Indiana; Comer Children’s Hospital,
Chicago, Illinois; and American Family Children’s Hospital, Madison, Wisconsin).25 Informed consent
was waived owing to minimal risk to participants. Original CT reports (denoted as R0) and pathology
records were queried from an operative registry of 521 primary lung lesions resected between
January 1, 2009, and December 31, 2015, and detailed elsewhere.26,27 All preoperative chest CT
scans were performed with intravenous contrast, using a variety of CT scanners with a minimum of
16 slices.28 This study followed the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) reporting guideline.

Eligibility Criteria
The study cohort generated for detailed CT analysis is shown in eFigure 1 in Supplement 1. All children
in the registry with evaluable preoperative chest CT images and an original imaging report were
screened. We excluded prenatally diagnosed lesions given the known association of PPB with an
initial diagnosis in the postnatal period.6,16,20,29,30 Computed tomography scans from pathologically
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confirmed cystic PPBs (cases) were then individually age-matched with CT scans from pathologically
confirmed benign CLMs (controls) at a target ratio of 1:3. We deliberately enriched for macrocystic
CPAMs when possible and selected against BPS and CPAM with systemic feeding vessels, given the
known association between systemic feeding vessels and benign disease.18 Images were stripped of
patient identifiers and uploaded to the InteleViewer picture achiving and communication system
(Intelerad Medical Systems Inc) for radiologic interpretation.

Variables
Board-certified pediatric radiologists were recruited to review these images in an independent and
blinded fashion from January 24, 2019, to September 6, 2020. Each radiologist had no knowledge of
the original CT diagnosis, pathologic diagnosis, and number or proportion of PPB lesions in the study
cohort. In addition to recording data on lesion characteristics and a final radiologic diagnosis, each
study radiologist provided a confidence level in (1) the radiologic diagnosis and (2) overall suspicion of
malignancy using 5-point Likert scales (range, 1-5, where 1 = very likely benign and 5 = almost
certainly malignant). Data were stored in a centralized REDCap database (Research Electronic Data
Capture, version 8.1.20; Vanderbilt University). Outcomes of interest were diagnostic accuracy,
interrater reliability, correlation of radiologist suspicion with pathology diagnosis, and radiologic
characterization of cystic PPB lesions.

Statistical Analysis
Statistical analysis was performed from January 18 to September 6, 2020, using standard parametric
methods for continuous and categorical variables. Binary logistic regression models were performed
as appropriate using Stata, version 16.1 (StataCorp LLC) or R Studio, version 3.6.1 (R Group for
Statistical Computing). All P values were from 2-sided tests and results were deemed statistically
significant at P < .05. Positive predictive values (PPVs) and negative predictive values (NPVs) were
calculated based on PPB prevalence estimates as described elsewhere.16,23 Interrater reliability was
assessed using the Cohen κ statistic and intraclass correlation coefficient with 2-way mixed-effects
modeling. The following levels of interrater agreement were used for interpretation: lower than
0.50 = poor, 0.50 to 0.74 = moderate, 0.75 to 0.90 = good, and higher than 0.90 = excellent.31

Results
Patient Characteristics
eTable 1 in Supplement 1 shows the baseline characteristics of the 477 registry patients (282 boys
[59%]; median age at CT, 3.6 months [IQR, 1.2-7.2 months]; median age at resection, 6.9 months
[IQR, 4.2-12.8 months]) with at least 1 preoperative CT scan. Pathologic diagnoses included BPS (158
patients [33%]), bronchial atresia (13 patients [3%]), bronchogenic cyst (31 patients [7%]),
congenital lobar emphysema (50 patients [11%]), CPAM (210 patients [44%]), and cystic PPB (11
patients [2%]). No malignant tumors were identified in the 314 lesions (66%) that were initially
detected prenatally.
Forty age-matched children (8%) with primary lung lesions were selected for detailed radiologic
review (eTable 1 in Supplement 1). There were 26 right-sided lesions (65%) and 15 left-sided lesions
(38%). The most common anatomic locations were right lower lobe (12 [30%]), right upper lobe (9
[23%]), and left lower lobe (8 [20%]). There were 20 CPAMs (50%) and 9 (23%) pathologically
confirmed cystic PPBs. In accordance with the study design, the cohort included significantly fewer
lung malformations associated with a systemic feeding vessel when compared with the entire
registry cohort. Adequacy of age matching between benign and malignant cases was demonstrated
by the lack of significant differences in median age at CT (benign, 7.3 months [IQR, 2.1-22.3 months]
vs malignant, 8.2 months [IQR, 4.0-70.1 months]; P = .75) and in median age at resection (benign, 8.7
months [IQR, 5.0-24.4 months] vs malignant, 10.1 months [IQR, 4.2-71.2 months]; P = .83).
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Diagnostic Accuracy
Original Radiologist
Data on the original diagnostic accuracy of chest CT for the 477 lesions are presented in eTable 2 in
Supplement 1. The sensitivity for detecting a CPAM was 87% (95% CI, 81%-91%) and the specificity
was 80% (95% CI, 75%-85%). The PPV for CPAM was 78% (95% CI, 73%-82%) and the NPV was
88% (95% CI, 84%-92%). For the other benign lung malformations, the sensitivity of CT was lower
(range, 41%-74%), but there was higher specificity (range, 96%-100%). The sensitivity for detecting
a malignant primary lesion was 33% (95% CI, 12%-62%) and the specificity was 99% (95% CI,
98%-100%). Based on the overall low prevalence of malignant lung lesions in the registry, the PPV
for a malignant primary lesion was 50% (95% CI, 25%-76%) and the NPV was 98% (95%
CI, 95%-98%).
Study Radiologists
There were 9 study radiologists (denoted as radiologists R1-R9) representing 6 different consortium
hospitals. They collectively completed a total of 346 of 360 interpretations (96%). Fourteen of 360
studies (4%) could not be evaluated by 2 study radiologists (R3 and R4) owing to hardware or
software compatibility issues. In addition to board certification among all reviewers, experience in
pediatric chest CT scan interpretation was confirmed by number of years after pediatric radiology
fellowship training (median, 9 years; range, 4-31 years). The median estimated number of lung lesion
CT scans reviewed annually per study radiologist was 10 (range, 2-15).
Table 1 compares the CT diagnosis for all images based on the original interpretation and the
study radiologist’s interpretation. The most common diagnosis in both groups was CPAM; study
radiologists were significantly less likely to interpret a study as CPAM compared with those analyzed
by the original interpretation (149 of 346 [43%] vs 29 of 40 [73%]; P = .009). Conversely, the
percentage of studies for which the study radiologists believed that PPB was the most likely diagnosis
was significantly increased when compared with those interpreted by the original radiologist (88 of
346 [25%] vs 3 of 40 [8%]; P = .008).
Among the study radiologists, the overall diagnostic accuracy, defined as the proportion of true
positives and true negatives, for all lung lesions was 81%. Study radiologists increased the sensitivity
for detecting a malignant primary lesion to 58% but had reduced specificity (83%) when compared
with the original CT interpretation (eTable 2 in Supplement 1). Based on the estimated disease
prevalence of PPB among postnatally diagnosed lung lesions,16 the calculated PPV was 24% and the
NPV was 95%. The sensitivity of the study radiologists for detecting a CPAM was 56% and the
specificity was 70%.

Table 1. Computed Tomography of 40 Lung Lesions: Original Interpretation vs Study Interpretation
No. (%)
Characteristic

Original
interpretation

Study
interpretationa

P value

No. of reads

40

346

NA

BPS

0

28 (8)

.10

Bronchial atresia

0

12 (4)

.62

Bronchogenic cyst

2 (5)

6 (2)

.20

CLE

2 (5)

25 (7)

>.99

CPAM

29 (73)

149 (43)

.009b

CPAM with systemic feeding vessel

1 (3)

21 (6)

.71

Infectious or pneumatoceles

2 (5)

3 (1)

.09

Computed tomography diagnosis

Miscellaneous benign

2 (5)

11 (3)

.63

Other malignant tumorc

0

4 (1)

>.99

PPB

3 (8)

88 (25)

.008b
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a

Nine radiologists independently reviewed the same
40 studies (3.9% noncompletion rate).

b

P < .05 (Fisher exact test).

c

Includes bronchoalveolar carcinoma and
pulmonary sarcoma.
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The variability in CT diagnosis is depicted by the heatmap shown in Figure 1. Although many
lesions were correctly diagnosed by CT, the heatmap revealed a discordance with pathologic
diagnosis in many cases, and there was lack of consensus in the radiologic diagnosis across the
spectrum of primary lung lesions. Congenital pulmonary airway malformations, congenital lobar
emphysema, bronchogenic cysts, and bronchial atresias were all misclassified as malignant tumors
and other types of benign lesions (Figure 2). For PPB, the false-positive rate was 18% (49 of 267
reads). Bronchopulmonary sequestration was the only CLM pathology that was not diagnosed as a
PPB by a radiologist. The interrater reliability score as measured by the intraclass correlation was 0.31
(95% CI, 0.18-0.49) and as measured by the combined κ statistic was 0.36 (range, 0.06-0.64). Both
values indicate poor agreement with regard to whether a given lesion was benign vs malignant.
To assess whether there might be an association between radiology experience and diagnostic
accuracy in the detection of PPB, we calculated the sensitivity and specificity for each study
radiologist and correlated these findings with their reported total number of lung lesion chest CT
scans reviewed since completion of fellowship training (eFigure 2 in Supplement 1). Although there
were no obvious differences in specificity rates associated with radiologist experience, lessexperienced radiologists tended to have lower sensitivity rates for detecting malignant lesions
compared with their more experienced colleagues.

Malignancy Risk Assessment
Based on a 5-point Likert scale (range, 1-5, where 1 = very likely benign and 5 = almost certainly
malignant), the mean (SD) overall diagnostic confidence score was 3.9 (0.9), signifying a moderateto-high level of diagnostic certainty by CT. The mean (SD) level of suspicion of malignancy was 1.9
(1.2), indicating a relatively low level of suspicion of malignancy within the study cohort. To assess the
association between CT and pathologic diagnosis, binary logistic regressions were performed based
on Likert scales (Table 2). This analysis revealed a significant, 6-fold increased risk for malignant
tumors based on a positive radiologist impression for PPB (odds ratio, 6.4; 95% CI, 2.8-14.5; P = .01).
Moreover, each additional 1 point on the Likert scale correlated with an increased risk for a PPB
diagnosis (suspicion level 2: odds ratio, 2.0; 95% CI, 1.2-3.3; and suspicion level 5: odds ratio, 13.5;
95% CI, 2.7-67.3).

Figure 1. Heatmap Illustrating the Variability in Computed Tomography (CT) Diagnosis Among 40 Lung Lesions
CPAM
BPS
CLE
BA
Other
PPB

Path

R0

R1

R2

R3

R4

R5

R6

R7

R8

R9

CT diagnosis
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The correct diagnosis (pathology) is indicated in the
far-left column. Nonevaluable studies are shown in
white. BA indicates bronchial atresia; BPS,
bronchopulmonary sequestration; CLE, congenital
lobar emphysema; CPAM, congenital pulmonary
airway malformation; Path, pathology; PPB,
pleuropulmonary blastoma; R0, original
interpretation; and R1-R9, study interpretation by 1 of
9 radiologists.
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CT Characteristics of PPB
To identify lesion characteristics on CT scans that might be correlated with PPB, specific imaging
findings were systematically reviewed (Table 3). Bivariate analysis showed that left upper lobe
lesions (benign, 4 of 31 [13%]; and malignant, 5 of 9 [56%]; P = .03) and macrocystic lesions (benign,
20 of 31 [65%]; and malignant, 9 of 9 [100%]; P = .04) were significantly associated with a
pathologic diagnosis of PPB. No CT characteristic was found to be significant for benign or malignant
disease in multivariable logistic regression.

Figure 2. Examples of Computed Tomography Images Reviewed by Study Radiologists
A Coronal view of lung in 2-month-old girl

B

C

D Axial view of lung in 5-month-old boy

Coronal view of lung in 5-month-old boy

Axial view of lung in 2-month-old girl

Representative coronal (A) and axial (B) lung window
images in a 2-month-old girl show a 5.5 × 2.6 × 8.9-cm
cystic lung lesion located in the medial right lower lobe
with thin internal septations. The pathologic diagnosis
was pleuropulmonary blastoma (PPB) but was
interpreted by 6 study radiologists as a benign
macrocystic congenital pulmonary airway
malformation (CPAM). Representative coronal (C) and
axial (D) lung window images in a 5-month-old boy
with a posterior left lower lobe 2.9 × 3.5 × 2.7-cm solid
lung lesion with an internal cyst. The pathologic
diagnosis was CPAM but was diagnosed by 6 study
radiologists as PPB.

Table 2. Correlation of Study Radiologists’ CT Diagnosis and Suspicion With Pathology Diagnosis
Characteristic

Odds ratio (95% CI)

P valuea

CT diagnosis of PPB

6.4 (2.8-14.5)

<.001

2

2.0 (1.2-3.3)

.006

3

3.7 (1.8-8.0)

.001

4

8.4 (2.6-27.1)

<.001

5

13.5 (2.7-67.3)

.002

Suspicion levelb
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b

Compared with a score of 1 (lowest suspicion) on a
5-point Likert scale.
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Discussion
The ability of cross-sectional imaging to discern between malignant and benign cystic lung lesions is
of critical importance in guiding preoperative counseling discussions with families and in deciding
whether to proceed with operative vs nonoperative management strategies.29 In this study, CT scans
from young children (median age, 7-8 months) with either a pathologically confirmed benign CLM
or confirmed malignant PPB were reviewed independently in a blinded fashion by a cohort of trained
pediatric radiologists. There are several important findings. First, CT scans have limited diagnostic
accuracy in terms of distinguishing between benign and malignant cystic lung disease. Among our
study radiologists, the sensitivity for detecting PPB was 58% and the overall specificity was 83%.
Less-experienced radiologists tended to have lower sensitivity rates for detecting malignant lesions
compared with more-experienced radiologists, and the overall diagnostic accuracy was 81%. Based
on reports from the original radiologist interpretation, the sensitivity for detecting PPB lesions was
33% and the specificity was 99%. Consistent with the difficulties in accurately diagnosing CLM
lesions in general, these data validate the handful of radiology report–based studies that document a
high rate of misdiagnosis of cystic PPB lesions as benign disease.20,32-34
Although the enhanced sensitivity observed by the study radiologists as a group may be a
function of their increased experience with this imaging modality for young children, the change in
study diagnostic accuracy may also be secondary to a Hawthorne effect,35 in which an increased
awareness of the study aims influenced a given radiologist’s threshold to diagnosis a cystic lesion as
malignant. The presence of a Hawthorne effect in our study therefore represents the best-case
scenario for detecting PPB among a group of benign lung lesions. Regardless, the difficulty in
establishing a CT diagnosis, which is further demonstrated by minimal interobserver agreement
among these reviewers, highlights the current limitations of chest CT in terms of distinguishing
benign and malignant cystic lung lesions in children. Other investigators have also observed that

Table 3. Computed Tomography Characteristics of Benign vs Malignant Lesions
No. (%)
Characteristic

Benign (n = 31)

Malignant (n = 9)

P value

Upper lobe

8 (26)

3 (33)

>.99

Middle lobe

4 (13)

0

.56

Lower lobe

12 (39)

1 (11)

.13

Upper lobe

4 (13)

5 (56)

.03a

Lower lobe

8 (26)

2 (22)

>.99

Right

20 (65)

3 (33)

.13

Left

9 (29)

5 (56)

.23

Bilateral

2 (7)

1 (11)

.55

Maximum cyst size, mean (SD), cm

6.3 (2.8)

6.9 (3.4)

.10

Solid portion

11 (36)

5 (56)

.44

Macrocystic (>1 cm)

20 (65)

9 (100)

.04a

Microcystic (<1 cm)

Anatomic location
Right

Left

Laterality

Cyst characteristics

2 (7)

0

>.99

Midline shift

14 (45)

4 (44)

>.99

Pneumothorax

0

1 (11)

.23

Pleural effusion

3 (10)

2 (22)

.31

Septations

15 (48)

8 (89)

.05

Chest wall invasion

1 (3)

0

>.99

Mediastinal lymph nodes

3 (10)

1 (11)

>.99
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cystic PPB may be indistinguishable from CPAM by CT.20-22,36 Although magnetic resonance imaging
may play a diagnostic role in a few cases, this imaging modality usually provides suboptimal
visualization of the lung parenchyma owing to low magnetic resonance signal from proton-poor
lung tissue.37
A second major finding from our study was the lack of specific imaging characteristics on CT
scans that help to reliably discern PPB lesions from macrocystic CPAMs. Genetic and histologic
investigations have confirmed distinct pathogenic mechanisms between these 2 pulmonary
diseases.21,38,39 Less than 5% of PPBs are detected prenatally.18,20,40,41 The only radiologic feature
that is thought to be pathognomic for benign disease is the presence of a systemic feeding vessel,16,18
and our study radiologists correctly excluded malignancy in their review of all confirmed BPS lesions.
The significance of other image-based characteristics in identifying PPB is more controversial.20 Prior
work based on radiology reports has suggested that certain features, particularly multifocalilty or
biliateral lesions, are more consistent with malignant disease.18,42 However, our study, which was
restricted to postnatally diagnosed lesions, revealed that bilateral disease, midline shift,
pneumothorax, and pleural effusion are uncommon and not specific for malignant pathology.43
Based on data from the International Pleuropulmonary Blastoma Registry (IPBR), the incidence of
bilateral involvement in cystic PPB was only 10% to 20%, multifocal disease ranged from 5% to 40%,
and pneumothorax was only 30%.18,22,44 Therefore, CT scans of most PPB lesions would not show
these high-risk characteristics. Data from IPBR-based studies have suggested that cystic PPB is
associated with larger cyst size,18,44 but our analysis did not find that overall maximum cyst size was
significantly larger in PPB lesions when compared with CPAMs enriched with macrocystic disease.
Contrary to previous studies that have described a right-sided predilection for PPB,20,43,45 we found
that left upper lobe involvement was significantly more common in PPB.
In spite of the inherent limitations of chest CT in terms of accurately detecting some PPB
lesions, our data did reveal that suspected PPB cases correlated with an increased likelihood for a
malignant pathologic diagnosis. In the most highly suspicious scans, there was a more than 13-fold
increased likelihood of PPB. These results are concordant with previous work suggesting a relatively
low false-positive rate of CT for a PPB diagnosis.16,18 However, when adjusted for the estimated
diseases prevalence of PPB, this translated to a PPV of only 24%, which is much lower than rates
from the original radiology reports and those reported elsewhere.18 One possible explanation for the
lower predictive values might be the absence of clinical data available at the time of interpretation.
Family history, DICER1 variant status, and clinical symptoms have all been shown to correlate with the
diagnosis of cystic PPB. Clinical symptoms of PPB can be insidious, and some children with PPB are
asymptomatic during the early stages.16,18,20,33 It has also been shown that heterozygous germline
DICER1 variants, which are inherited in an autosomal dominant fashion, have an estimated
penetrance of only 10% to 15%.46,47 Furthermore, there is a nontrivial rate of sporadic PPB cases in
children who have no positive family history of DICER1-related cancers.22 Some studies indicate that
one-third of histologically confirmed cystic PPBs are not associated with a DICER1 variant.18,44 Taken
together, these data would imply that reliable preoperative exclusion of a malignant tumor on the
basis of reassuring radiologic findings in combination with a negative test result for DICER1 variants is
not possible at the present time for any child with a postnatally detected macrocystic lung lesion.
Although the estimated NPV for a malignant lesion was 95%, our data reveal that many PPB
lesions may not be appropriately recognized when suggested management algorithms are
followed.18 We therefore advocate for operative management to confirm pathologic diagnosis in any
cystic lung lesion without an antenatal diagnosis and do not recommend routine expectant
management.48-50 Achieving total resection at an early age is associated with positive outcomes in
the management of PPB.33,40,44,51,52 Surgical resection of cystic PPB managed at a median age of
diagnosis at 8 months is associated with a 5-year survival rate of 91%. Most PPB deaths are
associated with progression to type II or III disease.21,44 Pleuropulmonary blastoma with solid
components, which have an older median age of diagnosis, are associated with bone, brain, and liver
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metastasis; require adjuvant therapy in addition to surgical resection; and have significantly lower
5-year survival rates (51%-73%).44

Limitations
This study has some limitations. Our study cohort of primary lung lesions was kept intentionally
small, thereby enabling a group of radiologists to carefully review 40 studies. However, as is inherent
to research on rare diseases, the relatively low numbers of PPB lesions evaluated may have resulted
in a lack of power to detect rare but statistically significant differences in imaging characteristics
associated with malignant tumors. Larger prospective studies to assess the role of specific imaging
features in pathologic diagnosis would likely require multidisciplinary, international collaborative
efforts through the IPBR or elsewhere, perhaps in combination with machine learning algorithms.53
There may have also been differences in CT image acquisition and image quality that hampered the
ability to interpret some of these images with optimal diagnostic accuracy. Additionally, in addition
to concerns about the Hawthorne effect, the external validity of our findings may be questioned
when applied to other pediatric hospital settings where the imaging technology and radiology
expertise required to interpret these CT scans may differ.

Conclusions
Based on this regional multi-institutional case-control study, our hypothesis that CT can reliably
discern between cystic PPBs and benign CLMs without a systemic feeding vessel should be rejected.
Consequently, operative management to confirm pathologic diagnosis is warranted in any cystic lung
lesion without prenatal detection.
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